Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis
<p>Abstract</p> <p>Background</p> <p>Catalase is an important antioxidant enzyme that regulates the level of intracellular hydrogen peroxide and hydroxyl radicals. The effects of catalase deficiency on albuminuria and progressive glomerulosclerosis have not yet been ful...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-03-01
|
| Series: | BMC Nephrology |
| Online Access: | http://www.biomedcentral.com/1471-2369/13/14 |
| _version_ | 1811310987210391552 |
|---|---|
| author | Takiue Keiichi Sugiyama Hitoshi Inoue Tatsuyuki Morinaga Hiroshi Kikumoto Yoko Kitagawa Masashi Kitamura Shinji Maeshima Yohei Wang Da-Hong Masuoka Noriyoshi Ogino Keiki Makino Hirofumi |
| author_facet | Takiue Keiichi Sugiyama Hitoshi Inoue Tatsuyuki Morinaga Hiroshi Kikumoto Yoko Kitagawa Masashi Kitamura Shinji Maeshima Yohei Wang Da-Hong Masuoka Noriyoshi Ogino Keiki Makino Hirofumi |
| author_sort | Takiue Keiichi |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Catalase is an important antioxidant enzyme that regulates the level of intracellular hydrogen peroxide and hydroxyl radicals. The effects of catalase deficiency on albuminuria and progressive glomerulosclerosis have not yet been fully elucidated. The adriamycin (ADR) nephropathy model is considered to be an experimental model of focal segmental glomerulosclerosis. A functional catalase deficiency was hypothesized to exacerbate albuminuria and the progression of glomerulosclerosis in this model.</p> <p>Methods</p> <p>ADR was intravenously administered to both homozygous acatalasemic mutant mice (C3H/AnLCs<sup>b</sup>Cs<sup>b</sup>) and control wild-type mice (C3H/AnLCs<sup>a</sup>Cs<sup>a</sup>). The functional and morphological alterations of the kidneys, including albuminuria, renal function, podocytic, glomerular and tubulointerstitial injuries, and the activities of catalase were then compared between the two groups up to 8 weeks after disease induction. Moreover, the presence of a mutation of the toll-like receptor 4 (<it>tlr4</it>) gene, which was previously reported in the C3H/HeJ strain, was investigated in both groups.</p> <p>Results</p> <p>The ADR-treated mice developed significant albuminuria and glomerulosclerosis, and the degree of these conditions in the ADR-treated acatalasemic mice was higher than that in the wild-type mice. ADR induced progressive renal fibrosis, renal atrophy and lipid peroxide accumulation only in the acatalasemic mice. In addition, the level of catalase activity was significantly lower in the kidneys of the acatalasemic mice than in the wild-type mice during the experimental period. The catalase activity increased after ADR injection in wild-type mice, but the acatalasemic mice did not have the ability to increase their catalase activity under oxidative stress. The C3H/AnL strain was found to be negative for the <it>tlr4 </it>gene mutation.</p> <p>Conclusions</p> <p>These data indicate that catalase deficiency plays an important role in the progression of renal injury in the ADR nephropathy model.</p> |
| first_indexed | 2024-04-13T10:08:45Z |
| format | Article |
| id | doaj.art-91df30c0ff71426eb73d044aa2b8b8d5 |
| institution | Directory Open Access Journal |
| issn | 1471-2369 |
| language | English |
| last_indexed | 2024-04-13T10:08:45Z |
| publishDate | 2012-03-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Nephrology |
| spelling | doaj.art-91df30c0ff71426eb73d044aa2b8b8d52022-12-22T02:50:59ZengBMCBMC Nephrology1471-23692012-03-011311410.1186/1471-2369-13-14Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosisTakiue KeiichiSugiyama HitoshiInoue TatsuyukiMorinaga HiroshiKikumoto YokoKitagawa MasashiKitamura ShinjiMaeshima YoheiWang Da-HongMasuoka NoriyoshiOgino KeikiMakino Hirofumi<p>Abstract</p> <p>Background</p> <p>Catalase is an important antioxidant enzyme that regulates the level of intracellular hydrogen peroxide and hydroxyl radicals. The effects of catalase deficiency on albuminuria and progressive glomerulosclerosis have not yet been fully elucidated. The adriamycin (ADR) nephropathy model is considered to be an experimental model of focal segmental glomerulosclerosis. A functional catalase deficiency was hypothesized to exacerbate albuminuria and the progression of glomerulosclerosis in this model.</p> <p>Methods</p> <p>ADR was intravenously administered to both homozygous acatalasemic mutant mice (C3H/AnLCs<sup>b</sup>Cs<sup>b</sup>) and control wild-type mice (C3H/AnLCs<sup>a</sup>Cs<sup>a</sup>). The functional and morphological alterations of the kidneys, including albuminuria, renal function, podocytic, glomerular and tubulointerstitial injuries, and the activities of catalase were then compared between the two groups up to 8 weeks after disease induction. Moreover, the presence of a mutation of the toll-like receptor 4 (<it>tlr4</it>) gene, which was previously reported in the C3H/HeJ strain, was investigated in both groups.</p> <p>Results</p> <p>The ADR-treated mice developed significant albuminuria and glomerulosclerosis, and the degree of these conditions in the ADR-treated acatalasemic mice was higher than that in the wild-type mice. ADR induced progressive renal fibrosis, renal atrophy and lipid peroxide accumulation only in the acatalasemic mice. In addition, the level of catalase activity was significantly lower in the kidneys of the acatalasemic mice than in the wild-type mice during the experimental period. The catalase activity increased after ADR injection in wild-type mice, but the acatalasemic mice did not have the ability to increase their catalase activity under oxidative stress. The C3H/AnL strain was found to be negative for the <it>tlr4 </it>gene mutation.</p> <p>Conclusions</p> <p>These data indicate that catalase deficiency plays an important role in the progression of renal injury in the ADR nephropathy model.</p>http://www.biomedcentral.com/1471-2369/13/14 |
| spellingShingle | Takiue Keiichi Sugiyama Hitoshi Inoue Tatsuyuki Morinaga Hiroshi Kikumoto Yoko Kitagawa Masashi Kitamura Shinji Maeshima Yohei Wang Da-Hong Masuoka Noriyoshi Ogino Keiki Makino Hirofumi Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis BMC Nephrology |
| title | Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| title_full | Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| title_fullStr | Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| title_full_unstemmed | Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| title_short | Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| title_sort | acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosis |
| url | http://www.biomedcentral.com/1471-2369/13/14 |
| work_keys_str_mv | AT takiuekeiichi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT sugiyamahitoshi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT inouetatsuyuki acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT morinagahiroshi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT kikumotoyoko acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT kitagawamasashi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT kitamurashinji acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT maeshimayohei acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT wangdahong acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT masuokanoriyoshi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT oginokeiki acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis AT makinohirofumi acatalasemicmicearemildlysusceptibletoadriamycinnephropathyandexhibitincreasedalbuminuriaandglomerulosclerosis |